256 related articles for article (PubMed ID: 27864417)
1. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
Nagarajan P; Curry JL; Ning J; Piao J; Torres-Cabala CA; Aung PP; Ivan D; Ross MI; Levenback CF; Frumovitz M; Gershenwald JE; Davies MA; Malpica A; Prieto VG; Tetzlaff MT
Clin Cancer Res; 2017 Apr; 23(8):2093-2104. PubMed ID: 27864417
[No Abstract] [Full Text] [Related]
2. Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis.
Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Insa A; Fortea JM
Melanoma Res; 2005 Jun; 15(3):169-77. PubMed ID: 15917698
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
[TBL] [Abstract][Full Text] [Related]
4. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
5. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
6. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later.
Verschraegen CF; Benjapibal M; Supakarapongkul W; Levy LB; Ross M; Atkinson EN; Bodurka-Bevers D; Kavanagh JJ; Kudelka AP; Legha SS
Int J Gynecol Cancer; 2001; 11(5):359-64. PubMed ID: 11737466
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.
Namikawa K; Aung PP; Gershenwald JE; Milton DR; Prieto VG
Cancer Med; 2018 Mar; 7(3):583-593. PubMed ID: 29464914
[TBL] [Abstract][Full Text] [Related]
8. Melanoma of the Vulva and Vagina: Surgical Management and Outcomes Based on a Clinicopathologic Reviewof 68 Cases.
Sinasac SE; Petrella TM; Rouzbahman M; Sade S; Ghazarian D; Vicus D
J Obstet Gynaecol Can; 2019 Jun; 41(6):762-771. PubMed ID: 30391279
[TBL] [Abstract][Full Text] [Related]
9. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases.
Seifried S; Haydu LE; Quinn MJ; Scolyer RA; Stretch JR; Thompson JF
Ann Surg Oncol; 2015; 22(6):1959-66. PubMed ID: 25384702
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival.
Ragnarsson-Olding BK; Nilsson BR; Kanter-Lewensohn LR; Lagerlöf B; Ringborg UK
Cancer; 1999 Oct; 86(7):1285-93. PubMed ID: 10506715
[TBL] [Abstract][Full Text] [Related]
11. Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.
Rees MJ; Liao H; Spillane J; Speakman D; McCormack C; Donahoe S; Pohl M; Webb A; Gyorki D; Henderson MA
Eur J Surg Oncol; 2016 Sep; 42(9):1359-66. PubMed ID: 26899940
[TBL] [Abstract][Full Text] [Related]
12. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
13. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of galectin-3 in primary cutaneous melanoma.
Buljan M; Šitum M; Tomas D; Milošević M; Krušlin B
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1174-81. PubMed ID: 21175876
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.
Chłopik A; Selim MA; Peng Y; Wu CL; Tell-Marti G; Paral KM; Shalin SC; Kraft S; Hsu CK; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
Hum Pathol; 2018 Mar; 73():176-183. PubMed ID: 29307625
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
Balch CM; Soong SJ; Gershenwald JE; Thompson JF; Reintgen DS; Cascinelli N; Urist M; McMasters KM; Ross MI; Kirkwood JM; Atkins MB; Thompson JA; Coit DG; Byrd D; Desmond R; Zhang Y; Liu PY; Lyman GH; Morabito A
J Clin Oncol; 2001 Aug; 19(16):3622-34. PubMed ID: 11504744
[TBL] [Abstract][Full Text] [Related]
17. Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas.
Wu Y; Li H; Tan L; Lai Y; Li Z
Hum Pathol; 2023 Jan; 131():87-97. PubMed ID: 36370822
[TBL] [Abstract][Full Text] [Related]
18. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
19. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma.
Tas F; Erturk K
Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma of the vulva: a clinicopathological study of 50 women.
Bradgate MG; Rollason TP; McConkey CC; Powell J
Br J Obstet Gynaecol; 1990 Feb; 97(2):124-33. PubMed ID: 2317465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
